Author: Keith Ashcroft

Stability Testing: Long-Term Quality Monitoring Post-Manufacture in Pharmaceuticals

Keith Ashcroft
|
December 9
|
0

Stability testing ensures pharmaceuticals remain safe and effective after manufacture. Learn how ICH guidelines, real-time monitoring, and AI are shaping long-term quality control in drug production.

How the FDA Ensures Generic Drug Safety Through Manufacturing Oversight

Keith Ashcroft
|
December 7
|
3

The FDA ensures generic drug safety through strict manufacturing standards, bioequivalence testing, and global inspections. Learn how generics are monitored from factory to pharmacy.

Prescription Delivery Services: Get Generic Medicines Delivered to Your Door

Keith Ashcroft
|
December 4
|
4

Get your PBS-approved generic medications delivered to your door with free shipping, real-time tracking, and no extra cost. Learn how online pharmacy delivery works in Australia and why it’s changing how people manage chronic conditions.

Hydrophilic vs Lipophilic Statins: What You Need to Know About Side Effects

Keith Ashcroft
|
December 3
|
5

Hydrophilic and lipophilic statins differ in how they move through the body, affecting muscle pain risk and drug interactions. Learn which statins are safer, what really causes side effects, and how to choose the right one for you.

Accidental Pediatric Medication Overdose: How to Prevent It and What to Do If It Happens

Keith Ashcroft
|
December 1
|
6

Accidental pediatric medication overdoses are preventable. Learn how child-resistant packaging, proper dosing, and locked storage can protect young children-and what to do if a child swallows medicine by mistake.

State Laws on Generic Drug Substitution: What Pharmacists and Patients Need to Know

Keith Ashcroft
|
December 1
|
8

State laws on generic drug substitution vary widely across the U.S., affecting how pharmacists swap brand-name drugs for generics. Learn how consent rules, NTI drug restrictions, and biosimilar policies differ by state-and what patients and pharmacists need to know.

180-Day Exclusivity in Generic Drug Market Entry: How Patent Law Controls Access

Keith Ashcroft
|
December 1
|
10

The 180-day exclusivity rule under the Hatch-Waxman Act gives the first generic drug maker to challenge a patent a temporary monopoly - but it often delays competition and keeps prices high. Here’s how it works, why it’s controversial, and what’s being done to fix it.

Vestibular Migraine: How to Manage Dizziness and Headaches Effectively

Keith Ashcroft
|
December 1
|
11

Vestibular migraine causes dizziness, vertigo, and headaches without always including pain. Learn how to diagnose it, avoid common misdiagnoses, and use proven treatments like propranolol, vestibular rehab, and supplements to manage symptoms effectively.

Metformin and Vitamin B12 Deficiency: What You Need to Know About Long-Term Risks

Keith Ashcroft
|
December 1
|
6

Long-term metformin use can cause vitamin B12 deficiency, leading to nerve damage, fatigue, and confusion. Learn the symptoms, who's at risk, and how to prevent irreversible complications with simple blood tests and supplements.

Antiemetics and Parkinson’s Medications: Avoiding Dangerous Dopamine Interactions

Keith Ashcroft
|
November 27
|
10

Dopamine-blocking antiemetics like metoclopramide can severely worsen Parkinson’s symptoms. Learn which drugs to avoid, safer alternatives like domperidone and cyclizine, and how to protect your movement from dangerous medication interactions.